• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主因素:在 COVID-19 免疫发病机制中的意义。

Host factors: Implications in immunopathogenesis of COVID-19.

机构信息

Department of Immunology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran; Immunology Today, Universal Scientific Education and Research Network (USERN), Tehan, Iran.

出版信息

Pathol Res Pract. 2021 Dec;228:153647. doi: 10.1016/j.prp.2021.153647. Epub 2021 Oct 12.

DOI:10.1016/j.prp.2021.153647
PMID:34749207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8505027/
Abstract

Coronavirus disease 2019 (COVID-19) is a viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is more serious in people with underlying diseases, but the cause of healthy people with progressive disease is largely unknown. Host genetic factors such as ACE2 variants, IFITM-3, HLA, TMRSS2, and furin polymorphisms appear to be one of the agents involved in the progression of the COVID-19 and outcome of the disease. This review discusses the general characteristics of SARS-CoV-2, including viral features, receptors, cell entry, clinical findings, and the main human genetic factors that may contribute to the pathogenesis of COVID-19 and get the patients' situation more complex. Further knowledge in this context may help to find a way to prevent and treat this viral pneumonia.

摘要

新型冠状病毒病(COVID-19)是由严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的病毒性疾病。患有基础疾病的人病情更为严重,但健康人群病情进展的原因在很大程度上尚不清楚。宿主遗传因素,如 ACE2 变体、IFITM-3、HLA、TMRSS2 和弗林蛋白酶多态性,似乎是参与 COVID-19 进展和疾病结局的因素之一。这篇综述讨论了 SARS-CoV-2 的一般特征,包括病毒特征、受体、细胞进入、临床发现以及可能导致 COVID-19 发病机制和使患者病情更为复杂的主要人类遗传因素。在这方面进一步的知识可能有助于找到预防和治疗这种病毒性肺炎的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61e/8505027/e4676fe91823/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61e/8505027/6b551dbd8df7/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61e/8505027/e4676fe91823/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61e/8505027/6b551dbd8df7/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61e/8505027/e4676fe91823/gr2_lrg.jpg

相似文献

1
Host factors: Implications in immunopathogenesis of COVID-19.宿主因素:在 COVID-19 免疫发病机制中的意义。
Pathol Res Pract. 2021 Dec;228:153647. doi: 10.1016/j.prp.2021.153647. Epub 2021 Oct 12.
2
ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.西班牙马德里的 ACE2、TMPRSS2 和 Furin 变体与 SARS-CoV-2 感染。
J Med Virol. 2021 Feb;93(2):863-869. doi: 10.1002/jmv.26319. Epub 2020 Jul 28.
3
Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19.宿主免疫多态性与 SARS-CoV-2 遗传变异性对 COVID-19 发展的影响。
Viruses. 2022 Jan 6;14(1):94. doi: 10.3390/v14010094.
4
Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection.人类 ACE2 基因变异体对冠状病毒感染的易感性。
J Virol. 2022 Jan 12;96(1):e0149221. doi: 10.1128/JVI.01492-21. Epub 2021 Oct 20.
5
Human genetic basis of coronavirus disease 2019.2019 年冠状病毒病的人类遗传基础。
Signal Transduct Target Ther. 2021 Sep 20;6(1):344. doi: 10.1038/s41392-021-00736-8.
6
Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry.通过分析 ACE2 介导的 SARS-CoV-2 进入的遗传和表观遗传多样性来评估 COVID-19 的易感性。
Pharmacogenomics. 2020 Dec;21(18):1311-1329. doi: 10.2217/pgs-2020-0092. Epub 2020 Nov 27.
7
Genetic and epigenetic factors associated with increased severity of Covid-19.与 COVID-19 严重程度增加相关的遗传和表观遗传因素。
Cell Biol Int. 2021 Jun;45(6):1158-1174. doi: 10.1002/cbin.11572. Epub 2021 Mar 1.
8
Variable Clinical Manifestations of COVID-19: Viral and Human Genomes Talk.COVID-19 的多变临床表现:病毒与人类基因组的对话。
Iran J Allergy Asthma Immunol. 2020 Oct 18;19(5):456-470. doi: 10.18502/ijaai.v19i5.4461.
9
Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology.SARS-CoV-2 宿主细胞进入因子在健康个体免疫系统成分中的表达及其与 COVID-19 免疫病理的相关性。
Viral Immunol. 2021 Jun;34(5):352-357. doi: 10.1089/vim.2020.0277. Epub 2021 Jan 21.
10
Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West?遗传易感性是否导致合并症患者 COVID-19 症状加重,并解释东西方巨大的死亡率差异?
Int J Mol Sci. 2021 May 8;22(9):5000. doi: 10.3390/ijms22095000.

引用本文的文献

1
Genetic variants in influence SARS-CoV-2 infection susceptibility within Mexican Mestizos.基因变异影响墨西哥梅斯蒂索人对新冠病毒的感染易感性。
Front Genet. 2025 Apr 14;16:1558189. doi: 10.3389/fgene.2025.1558189. eCollection 2025.
2
Expression, Purification, and Evaluation of Antibody Responses and Antibody-Immunogen Complex Simulation of a Designed Multi-Epitope Vaccine against SARS-COV-2.针对 SARS-COV-2 的设计多表位疫苗的抗体反应和抗体-免疫原复合物模拟的表达、纯化和评估。
Protein Pept Lett. 2024;31(8):619-638. doi: 10.2174/0109298665320319240809095727.
3
Occurrence of COVID-19 in cystic fibrosis patients: a review.

本文引用的文献

1
Host/genetic factors associated with COVID-19 call for precision medicine.与新冠肺炎相关的宿主/遗传因素需要精准医学。
Precis Clin Med. 2020 Jul 21;3(3):228-234. doi: 10.1093/pcmedi/pbaa026. eCollection 2020 Sep.
2
Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus.综合分析鉴定 SLC6A20 和 CXCR6 为 COVID-19 3p21.31 位点 GWAS 信号的潜在因果基因。
Genome Biol. 2021 Aug 23;22(1):242. doi: 10.1186/s13059-021-02454-4.
3
Association of CXCR6 with COVID-19 severity: delineating the host genetic factors in transcriptomic regulation.
囊性纤维化患者中新型冠状病毒肺炎的发生情况:一项综述
Front Microbiol. 2024 Apr 17;15:1356926. doi: 10.3389/fmicb.2024.1356926. eCollection 2024.
4
Genetic variant rs1205 is associated with COVID-19 outcomes: The Strong Heart Study and Strong Heart Family Study.基因变体rs1205与新冠病毒疾病(COVID-19)的预后相关:强心研究和强心家族研究
PLoS One. 2024 Apr 25;19(4):e0302464. doi: 10.1371/journal.pone.0302464. eCollection 2024.
5
T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles.在独特的本土 HLA 谱背景下的 T 细胞表位发现。
Front Immunol. 2022 May 6;13:812393. doi: 10.3389/fimmu.2022.812393. eCollection 2022.
CXCR6 与 COVID-19 严重程度的关联:解析转录组调控中的宿主遗传因素。
Hum Genet. 2021 Sep;140(9):1313-1328. doi: 10.1007/s00439-021-02305-z. Epub 2021 Jun 21.
4
Genetic and epigenetic factors associated with increased severity of Covid-19.与 COVID-19 严重程度增加相关的遗传和表观遗传因素。
Cell Biol Int. 2021 Jun;45(6):1158-1174. doi: 10.1002/cbin.11572. Epub 2021 Mar 1.
5
SARS-CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges.严重急性呼吸综合征冠状病毒2型的免疫发病机制以及多种疫苗和疗法的潜力:机遇与挑战
Infect Dis Rep. 2021 Feb 4;13(1):102-125. doi: 10.3390/idr13010013.
6
Manipulation of ACE2 expression in COVID-19.调控 COVID-19 中的 ACE2 表达。
Open Heart. 2020 Dec;7(2). doi: 10.1136/openhrt-2020-001424.
7
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.严重急性呼吸综合征冠状病毒2刺突糖蛋白的结构、功能及抗原性
Cell. 2020 Dec 10;183(6):1735. doi: 10.1016/j.cell.2020.11.032.
8
"Neurological manifestations of COVID-19" - guideline of the German society of neurology.《新型冠状病毒肺炎的神经学表现》——德国神经病学学会指南
Neurol Res Pract. 2020 Dec 2;2:51. doi: 10.1186/s42466-020-00097-7. eCollection 2020.
9
Little to no expression of angiotensin-converting enzyme-2 on most human peripheral blood immune cells but highly expressed on tissue macrophages.大多数人外周血免疫细胞上很少或几乎没有血管紧张素转换酶 2 的表达,但组织巨噬细胞上高度表达。
Cytometry A. 2023 Feb;103(2):136-145. doi: 10.1002/cyto.a.24285. Epub 2020 Dec 16.
10
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.CD147-刺突蛋白是 SARS-CoV-2 感染宿主细胞的新途径。
Signal Transduct Target Ther. 2020 Dec 4;5(1):283. doi: 10.1038/s41392-020-00426-x.